Science Explorer Back to mapMap
Discussion
Company · Lexington · United States

ActivBiotics (United States)

ROR OpenAlex
Research works
19
▲ 152% vs 2018-21
Citations
308
16.1 per fractional work
Top-10% rate
9.6%
all institutions 10.0%
Open access
28%
world 40%
International
21%
world 18%
ActivBiotics (United States)

Not ranked overall: ActivBiotics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ActivBiotics (United States) work in?

In all years, 43% of research at ActivBiotics (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (36%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (14%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 8 fractional works · 43.5% of its workMedicine: 7 fractional works · 36.2% of its workInfectious Diseases: 2 fractional works · 9.9% of its workPharmacology: 1 fractional works · 7.1% of its workSurgery: 1 fractional works · 6.7% of its workEpidemiology: 1 fractional works · 5.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.6% of its workPhysiology: 0 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.3% of its workVeterinary: 1 fractional works · 6.7% of its workSmall Animals: 1 fractional works · 6.7% of its workHealth Professions: 0 fractional works · 0.6% of its workGeneral Health Professions: 0 fractional works · 0.6% of its workLife Sciences: 7 fractional works · 38.4% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 19.9% of its workMolecular Biology: 3 fractional works · 13.4% of its workMolecular Medicine: 1 fractional works · 6.1% of its workGenetics: 0 fractional works · 0.4% of its workImmunology and Microbiology: 3 fractional works · 14.2% of its workMicrobiology: 2 fractional works · 8.9% of its workImmunology: 1 fractional works · 5.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.6% of its workPharmacology: 0 fractional works · 2.6% of its workAgricultural and Biological Sciences: 0 fractional works · 1.7% of its workPlant Science: 0 fractional works · 1.7% of its workPhysical Sciences: 3 fractional works · 17.0% of its workChemistry: 1 fractional works · 5.2% of its workOrganic Chemistry: 1 fractional works · 4.3% of its workAnalytical Chemistry: 0 fractional works · 0.9% of its workEngineering: 1 fractional works · 4.8% of its workControl and Systems Engineering: 0 fractional works · 1.7% of its workMechanical Engineering: 0 fractional works · 1.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.9% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 1 fractional works · 4.3% of its workPollution: 1 fractional works · 3.5% of its workEcology: 0 fractional works · 0.9% of its workComputer Science: 0 fractional works · 1.7% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.7% of its workMaterials Science: 0 fractional works · 0.9% of its workPolymers and Plastics: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.6% of its workSocial Psychology: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 0.6% of its workLife-span and Life-course Studies: 0 fractional works · 0.6% of its workALL ITS WORKActivBiotics(United States)19fractional works, all years
Life Sciences38%Physical Sciences17%Health Sciences43%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine736.2%
    2. Veterinary16.7%
    3. Health Professions00.6%
    1. Biochemistry, Genetics and Molecular Biology419.9%
    2. Immunology and Microbiology314.2%
    3. Pharmacology, Toxicology and Pharmaceutics02.6%
    4. Agricultural and Biological Sciences01.7%
    1. Chemistry15.2%
    2. Engineering14.8%
    3. Environmental Science14.3%
    4. Computer Science01.7%
    5. Materials Science00.9%
    1. Psychology00.6%
    2. Social Sciences00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at ActivBiotics (United States)?

Ranked on the quality score, Christopher K. Murphy and John van Duzer lead among researchers whose main affiliation is ActivBiotics (United States).

  1. 1 Christopher K. Murphy United States · #736,494 worldwide 1.6k citations · 38 works
  2. 2 John van Duzer United States · #2,150,421 worldwide 411 citations · 18 works
All ranked researchers at ActivBiotics (United States)

What are the most cited papers from ActivBiotics (United States)?

The most cited paper from ActivBiotics (United States) is "Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2" (Ronald E. Esser, Carol Berry, Zhengming Du et al., 2005), with 123 citations. Next come "Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters" (86) and "Rifalazil Treats and Prevents Relapse of Clostridium difficile -Associated Diarrhea in Hamsters" (65).

Most cited papers
#PaperReleasedCitations
1 Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase‐2 Ronald E. Esser, Carol Berry, Zhengming Du et al. · British Journal of Pharmacology Open access 17 Jan 2005 123
2 Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in Hamsters Christopher K. Murphy, Edward G. Fey, Brynmor A. Watkins et al. · Clinical Cancer Research Jul 2008 86
3 Rifalazil Treats and Prevents Relapse of Clostridium difficile -Associated Diarrhea in Hamsters Pauline M. Anton, Michael J. O’Brien, Efi G. Kokkotou et al. · Antimicrobial Agents and Chemotherapy Open access 23 Sep 2004 65
4 A Randomized, Double-Blind Study Comparing Single-Dose Rifalazil With Single-Dose Azithromycin for the Empirical Treatment of Nongonococcal Urethritis in Men Walter E. Stamm, Byron E. Batteiger, William M. McCormack et al. · Sexually Transmitted Diseases 9 Feb 2007 54
5 Efficacy of a Novel Rifamycin Derivative, ABI-0043, against Staphylococcus aureus in an Experimental Model of Foreign-Body Infection Andrej Trampuž, Christopher K. Murphy, David M. Rothstein et al. · Antimicrobial Agents and Chemotherapy Open access 15 May 2007 54
All 32 most cited papers, with filters and sorting

Which research topics does ActivBiotics (United States) publish most on?

By volume in 2022-now: Thermoregulation and physiological responses, Optical Imaging and Spectroscopy Techniques, Angiogenesis and VEGF in Cancer and Cerebrovascular and Carotid Artery Diseases.

Thermoregulation and phy…0Thermoregulation and physiological responses: 0 fractional worksOptical Imaging and Spec…0Optical Imaging and Spectroscopy Techniques: 0 fractional worksAngiogenesis and VEGF in…0Angiogenesis and VEGF in Cancer: 0 fractional worksCerebrovascular and Caro…0Cerebrovascular and Carotid Artery Diseases: 0 fractional worksPhotoacoustic and Ultras…0Photoacoustic and Ultrasonic Imaging: 0 fractional worksBody Contouring and Surg…0Body Contouring and Surgery: 0 fractional works
PhysiologyRadiology, Nuclear Medicine and ImagingMolecular BiologyPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Thermoregulation and physiological responses Physiology 0 works
  2. 2 Optical Imaging and Spectroscopy Techniques Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
  4. 4 Cerebrovascular and Carotid Artery Diseases Pulmonary and Respiratory Medicine 0 works
  5. 5 Photoacoustic and Ultrasonic Imaging Biomedical Engineering 0 works
  6. 6 Body Contouring and Surgery Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.9%not open72.1%

World: 40% of research is openly available.

with international co-authors21.3%domestic only78.7%

World: 18% is written across borders.

How has ActivBiotics (United States)'s research output changed?

Output in 2022-2025 was 152% higher than in 2018-2021.

2005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ActivBiotics (United States) as a percentage of every work published that year, 0.0000096% in 2022.

0.00010%0.00020%0.00030%ActivBiotics (United States)0.0000061% in 202320102020

Fractional works of ActivBiotics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ActivBiotics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.